Stay updated on SAGE-217 for Severe Depression Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 for Severe Depression Clinical Trial page.

Latest updates to the SAGE-217 for Severe Depression Clinical Trial page
- Check7 days agoChange DetectedThe updates appear to be minor formatting/layout changes with no new core content, study results, eligibility criteria, or outcome measures added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedAdded Revision: v3.4.2. Removed the lapse in government funding notice and Revision: v3.4.1 from the page.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a government-funding lapse notice clarifying site status and updated the page revision from 3.4.0 to 3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and updated study record metadata to display 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The previous version displayed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page shows a new Revision: v3.3.4 and removal of Revision: v3.3.3 in the version history, reflecting a metadata update to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a consolidated Locations section listing eight state sites (California, Florida, Georgia, Louisiana, New Jersey, Ohio, Texas, Virginia) and updated the revision to v3.3.3. Removed the separate per-state Location headings and the HHS Vulnerability Disclosure link.SummaryDifference0.7%

Stay in the know with updates to SAGE-217 for Severe Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 for Severe Depression Clinical Trial page.